These 3 Stocks Just Hit All-Time Highs — And They Still Look Unstoppable

It’s always hard to buy a stock that’s trading at an all-time high. Nobody wants to pay top-dollar for shares only to find out that they couldn’t have picked a worse time to invest…

Yet with so many of the top-performing stocks in the market, you simply can’t wait for a big bargain opportunity to arise. If you’re not willing to buy shares at or near all-time highs, then you might never get a chance to invest, and you’ll miss out on a huge opportunity to boost your overall returns.

Below, we’ll reveal three well-known companies that just hit all-time highs. Even though their share prices have already risen sharply, each of them has more room for future growth — and a strong track record of extraordinary business execution.

1. Alphabet

Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG) is a favorite among tech investors, largely because of the dominant position that its Google division has in online search and advertising. As one of the original FAANG stocks , Alphabet has seen its stock soar since its 2004 IPO.

Alphabet continues to retain its huge advantage in internet search, with recent states giving the tech giant a 92% share of web searches. In addition, Google’s Android operating system has become the standard for the majority of smartphones across the globe, with only Apple‘s (NASDAQ:AAPL) iOS mounting any considerable challenge to Alphabet’s supremacy.

Looking ahead, Alphabet has plenty of growth drivers. Google will continue to be a cash cow and should benefit from a recovery in the advertising market. Development in areas like artificial intelligence and autonomous vehicles is going well, and despite regulatory pressure, the business overall remains solid.

Perhaps best of all, even though Alphabet has risen to all-time highs, its stock performance has lagged that of other FAANG stocks. Even just catching up to the higher returns that Apple and others have generated would give Alphabet shareholders a nice payoff in 2021 and beyond.

2. Johnson & Johnson

Johnson & Johnson (NYSE:JNJ) is arguably the most important company in the healthcare industry. J&J’s pharmaceutical division is the biggest part of the company, with plenty of ground-breaking treatments that have helped millions of patients around the world. It also has a large consumer-health segment that’s responsible for well-known brands like Tylenol pain relievers and Band-Aid bandages. Johnson & Johnson’s medical-device segment is also an industry leader.

Over the long run, pharmaceuticals have been the largest driver of growth, as new pipeline-candidate treatments have consistently gained approval to replace older treatments losing their patent protection. Yet much of the recent hype about J&J has come from its role in…

Continue reading at THE MOTLEY FOOL

 

Leave a Reply

Your email address will not be published. Required fields are marked *